{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:16:05Z","timestamp":1778040965903,"version":"3.51.4"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["UM1TR004402"],"award-info":[{"award-number":["UM1TR004402"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002605","name":"American Society of Regional Anesthesia and Pain Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS094389"],"award-info":[{"award-number":["R01-NS094389"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neuropharm.2026.110967","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:56:35Z","timestamp":1775782595000},"page":"110967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ozanimod and other sphingosine-1-phosphate receptor 1 modulators normalize neuropathic injury-enhanced inhibition of central lateral amygdala neurons expressing corticotropin-releasing hormone"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-1723","authenticated-orcid":false,"given":"Regan C.","family":"Hines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2067-0941","authenticated-orcid":false,"given":"Abigail E.","family":"O'Sullivan-Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-2924","authenticated-orcid":false,"given":"Patrick L.","family":"Sheets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110967_bib1","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1208248","article-title":"GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood","volume":"333","author":"Arnon","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110967_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.brainres.2015.07.055","article-title":"GluN2B-containing NMDA receptors are upregulated in plasma membranes by the sphingosine-1-phosphate analog FTY720P","volume":"1624","author":"Attiori Essis","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110967_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.410040511","article-title":"Endogenous pain control mechanisms: review and hypothesis","volume":"4","author":"Basbaum","year":"1978","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0301-0082(95)00009-K","article-title":"Functional characteristics of the midbrain periaqueductal gray","volume":"46","author":"Behbehani","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.0b013e31823fcdee","article-title":"Periaqueductal gray: an interface for behavioral control","volume":"78","author":"Benarroch","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2026.110967_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cne.903290205","article-title":"The organization of the efferent projections from the pontine parabrachial area to the amygdaloid complex: a Phaseolus vulgaris leucoagglutinin (PHA-L) study in the rat","volume":"329","author":"Bernard","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pneurobio.2012.01.009","article-title":"GPCR mediated regulation of synaptic transmission","volume":"96","author":"Betke","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/mol.117.109140","article-title":"S1P(1) modulator-induced G (\u03b1)(i) signaling and \u03b2-Arrestin recruitment are both necessary to induce rapid and efficient reduction of blood lymphocyte count in vivo","volume":"93","author":"Birker-Robaczewska","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1744-8069-10-26","article-title":"A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments","volume":"10","author":"Bonin","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2026.110967_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132058","article-title":"Sphingosine-1-Phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives","volume":"11","author":"Bravo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.110967_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.110967_bib12","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1523\/JNEUROSCI.3536-06.2007","article-title":"Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception","volume":"27","author":"Carrasquillo","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2026.110967_bib14","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1073\/pnas.1820466116","article-title":"Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature09559","article-title":"Encoding of conditioned fear in central amygdala inhibitory circuits","volume":"468","author":"Ciocchi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110967_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-8993(95)00525-U","article-title":"An electrophysiological characterization of the projection from the central nucleus of the amygdala to the periaqueductal gray of the rat: the role of opioid receptors","volume":"689","author":"da Costa Gomez","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110967_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.mp.4000812","article-title":"The amygdala: vigilance and emotion","volume":"6","author":"Davis","year":"2001","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110967_bib18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuron.2014.04.042","article-title":"Amygdala microcircuits controlling learned fear","volume":"82","author":"Duvarci","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110967_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.conb.2018.02.009","article-title":"New perspectives on central amygdala function","volume":"49","author":"Fadok","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib20","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2147\/DDDT.S240861","article-title":"An overview of the efficacy and safety of ozanimod for the treatment of relapsing multiple sclerosis","volume":"15","author":"Fronza","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuropharm.2026.110967_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-0173(84)90012-2","article-title":"Subnuclear organization of the efferent connections of the parabrachial nucleus in the rat","volume":"319","author":"Fulwiler","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110967_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1113\/eph8702357","article-title":"Pain pathways and parabrachial circuits in the rat","volume":"87","author":"Gauriau","year":"2002","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib23","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1097\/j.pain.0000000000003770","article-title":"Ozanimod, a functional sphingosine-1-phosphate receptor 1 antagonist, restores brainstem descending pain pathways in murine models of neuropathic pain","volume":"166","author":"Giancotti","year":"2025","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.110967_bib24","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1111\/j.1460-9568.2012.08235.x","article-title":"Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation","volume":"36","author":"Goncalves","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0196-9781(92)90074-D","article-title":"Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat","volume":"13","author":"Gray","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2026.110967_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neulet.2003.12.027","article-title":"Synaptic plasticity in the amygdala in a visceral pain model in rats","volume":"361","author":"Han","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.110967_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0361-9230(94)90079-5","article-title":"Corticotropin releasing factor neurons are innervated by calcitonin gene-related peptide terminals in the rat central amygdaloid nucleus","volume":"33","author":"Harrigan","year":"1994","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.110967_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature09553","article-title":"Genetic dissection of an amygdala microcircuit that gates conditioned fear","volume":"468","author":"Haubensak","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110967_bib29","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/1389450116666151001112710","article-title":"Sphingosine-1-Phosphate receptors in the central nervous and immune systems","volume":"17","author":"Healy","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2026.110967_bib30","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1523\/JNEUROSCI.2067-21.2022","article-title":"GABAergic CaMKIIalpha+ amygdala output attenuates pain and modulates emotional-motivational behavior via parabrachial inhibition","volume":"42","author":"Hogri","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib31","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0367-16.2017","article-title":"Intrinsic circuits in the lateral central amygdala","volume":"4","author":"Hunt","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2026.110967_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pain.2006.09.003","article-title":"NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain","volume":"127","author":"Ikeda","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.110967_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0361-9230(95)02084-5","article-title":"Parabrachial nucleus projection to the amygdala in the rat: electrophysiological and anatomical observations","volume":"39","author":"Jhamandas","year":"1996","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.110967_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1744-8069-5-21","article-title":"NR2B receptor blockade inhibits pain-related sensitization of amygdala neurons","volume":"5","author":"Ji","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2026.110967_bib35","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1152\/jn.00135.2007","article-title":"Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala","volume":"97","author":"Ji","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9982020","article-title":"PET study of Sphingosine-1-phosphate receptor 1 expression in response to S. aureus infection","volume":"2021","author":"Jiang","year":"2021","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.neuropharm.2026.110967_bib37","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/MCB.01465-06","article-title":"Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons","volume":"27","author":"Kajimoto","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neuroscience.2010.10.021","article-title":"Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus","volume":"171","author":"Kanno","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110967_bib39","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/glia.23663","article-title":"Neural sphingosine 1-phosphate accumulation activates microglia and links impaired autophagy and inflammation","volume":"67","author":"Karunakaran","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2026.110967_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114669","article-title":"Cells and circuits for amygdala neuroplasticity in the transition to chronic pain","volume":"43","author":"Kiritoshi","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.110967_bib41","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s40265-020-01319-7","article-title":"Ozanimod: first approval","volume":"80","author":"Lamb","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2026.110967_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"LeDoux","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib43","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.08-07-02517.1988","article-title":"Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear","volume":"8","author":"LeDoux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nn.3322","article-title":"Experience-dependent modification of a central amygdala fear circuit","volume":"16","author":"Li","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149753","article-title":"Corticotropin-releasing hormone neurons in the central Amygdala: an integrative hub for pain, emotion, and addiction neurobiology","volume":"1863","author":"Li","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110967_bib50","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1152\/jn.00495.2006","article-title":"Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain","volume":"96","author":"Li","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pain.2004.03.015","article-title":"Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain","volume":"110","author":"Li","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.110967_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/jn.00485.2003","article-title":"Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons","volume":"91","author":"Li","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib46","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1113\/JP276935","article-title":"The central amygdala to periaqueductal gray pathway comprises intrinsically distinct neurons differentially affected in a model of inflammatory pain","volume":"596","author":"Li","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/j.pain.0000000000001691","article-title":"Spared nerve injury differentially alters parabrachial monosynaptic excitatory inputs to molecularly specific neurons in distinct subregions of the central amygdala","volume":"161","author":"Li","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.110967_bib51","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78610","article-title":"Cellular mechanisms underlying central sensitization in a mouse model of chronic muscle pain","volume":"11","author":"Lin","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.110967_bib52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.yhbeh.2007.04.012","article-title":"CRF type 1 receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors","volume":"52","author":"Litvin","year":"2007","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2026.110967_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112448","article-title":"Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review","volume":"18","author":"Mahajan-Thakur","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib54","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.bmcl.2018.10.042","article-title":"An update on sphingosine-1-phosphate receptor 1 modulators","volume":"28","author":"Marciniak","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuropharm.2026.110967_bib55","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181612","article-title":"S1P(1) receptor phosphorylation, internalization, and interaction with rab proteins: effects of sphingosine 1-phosphate, FTY720-P, phorbol esters, and paroxetine","volume":"38","author":"Mart\u00ednez-Morales","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110967_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109031","article-title":"Optogenetic manipulations of CeA-CRF neurons modulate pain- and anxiety-like behaviors in neuropathic pain and control rats","volume":"210","author":"Mazzitelli","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110967_bib57","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0010-18.2018","article-title":"Quantified coexpression analysis of central amygdala subpopulations","volume":"5","author":"McCullough","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2026.110967_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/cne.902080409","article-title":"Cytoarchitecture of the central amygdaloid nucleus of the rat","volume":"208","author":"McDonald","year":"1982","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1242\/dev.094805","article-title":"Sphingosine 1-phosphate signalling","volume":"141","author":"Mendelson","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2026.110967_bib60","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yhbeh.2011.06.004","article-title":"Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice","volume":"60","author":"Miguel","year":"2011","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2026.110967_bib61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib62","article-title":"Developing a 3-D computational model of neurons in the central amygdala to understand pharmacological targets for pain","volume":"4","author":"Miller Neilan","year":"2023","journal-title":"Front Pain Res (Lausanne)"},{"key":"10.1016\/j.neuropharm.2026.110967_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/492659","article-title":"Exogenous S1P exposure potentiates ischemic stroke damage that is reduced possibly by inhibiting S1P receptor signaling","volume":"2015","author":"Moon","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2026.110967_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108885","article-title":"Sphingosine-1-phosphate receptor 1 agonist SEW2871 alters membrane properties of late-firing somatostatin expressing neurons in the central lateral amygdala","volume":"203","author":"Mork","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110967_bib65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nchembio.173","article-title":"Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors","volume":"5","author":"Mullershausen","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-815134-1.00004-0","article-title":"Amygdala physiology in pain","volume":"26","author":"Neugebauer","year":"2020","journal-title":"Handb. Behav. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1073858403261077","article-title":"The amygdala and persistent pain","volume":"10","author":"Neugebauer","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2026.110967_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108052","article-title":"Amygdala, neuropeptides, and chronic pain-related affective behaviors","volume":"170","author":"Neugebauer","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110967_bib67","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1152\/jn.00799.2002","article-title":"Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain","volume":"89","author":"Neugebauer","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib70","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40263-024-01116-w","article-title":"Ozanimod: a review in relapsing forms of multiple sclerosis","volume":"38","author":"Nie","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2026.110967_bib71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1369\/jhc.2010.956409","article-title":"Cellular localization of sphingosine-1-phosphate receptor 1 expression in the human central nervous system","volume":"58","author":"Nishimura","year":"2010","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2026.110967_bib72","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1074\/jbc.M610318200","article-title":"Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor","volume":"282","author":"Oo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110967_bib73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4062\/biomolther.2016.160","article-title":"Sphingosine 1-Phosphate receptor modulators and drug discovery","volume":"25","author":"Park","year":"2017","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.neuropharm.2026.110967_bib74","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1523\/JNEUROSCI.4166-13.2014","article-title":"Fear conditioning potentiates synaptic transmission onto long-range projection neurons in the lateral subdivision of central amygdala","volume":"34","author":"Penzo","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib75","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0166-2236(97)01125-9","article-title":"Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala","volume":"20","author":"Pitkanen","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnins.2015.00487","article-title":"A transgenic rat for investigating the anatomy and function of corticotrophin releasing factor circuits","volume":"9","author":"Pomrenze","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib77","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.chembiol.2012.07.016","article-title":"A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis","volume":"19","author":"Quancard","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.903030111","article-title":"Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity","volume":"303","author":"Rizvi","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib79","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.cgh.2024.03.042","article-title":"Ozanimod in patients with moderate to severe ulcerative colitis naive to advanced therapies","volume":"22","author":"Sands","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib80","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuron.2016.11.034","article-title":"A central amygdala CRF circuit facilitates learning about weak threats","volume":"93","author":"Sanford","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110967_bib81","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/(SICI)1097-4547(19991201)58:5<663::AID-JNR7>3.0.CO;2-A","article-title":"Characterization of the electrophysiological and morphological properties of rat central amygdala neurons in vitro","volume":"58","author":"Schiess","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2026.110967_bib82","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bph.13476","article-title":"Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity","volume":"173","author":"Scott","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lfs.2013.06.004","article-title":"Sphingosine lysolipids in the CNS: endogenous cannabinoid antagonists or a parallel pain modulatory system?","volume":"93","author":"Selley","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib84","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.2009.06202.x","article-title":"Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS","volume":"110","author":"Sim-Selley","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110967_bib85","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.118.248260","article-title":"Differential tolerance to FTY720-Induced antinociception in acute thermal and nerve injury mouse pain models: role of Sphingosine-1-Phosphate receptor adaptation","volume":"366","author":"Sim-Selley","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110967_bib86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tips.2009.05.008","article-title":"G-protein-coupled-receptor-mediated presynaptic inhibition in the cerebellum","volume":"30","author":"Stephens","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110967_bib87","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1113\/jphysiol.2004.080192","article-title":"G protein {beta}{gamma} subunits mediate presynaptic inhibition of transmitter release from rat superior cervical ganglion neurones in culture","volume":"563","author":"Stephens","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib88","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20170584","article-title":"Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain","volume":"215","author":"Stockstill","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2026.110967_bib89","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1152\/jn.00946.2015","article-title":"Synaptic and network consequences of monosynaptic nociceptive inputs of parabrachial nucleus origin in the central amygdala","volume":"115","author":"Sugimura","year":"2016","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.110967_bib90","first-page":"100","article-title":"Ephus: multipurpose data acquisition software for neuroscience experiments","volume":"4","author":"Suter","year":"2010","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2026.110967_bib91","article-title":"A real-world data analysis of ozanimod in the FDA adverse event reporting system (FAERS) database","volume":"104","author":"Tang","year":"2025","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.neuropharm.2026.110967_bib92","article-title":"The parabrachial to central amygdala pathway is critical to injury-induced pain sensitization in mice","author":"Torres-Rodriguez","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110967_bib93","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/1087057108326144","article-title":"beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1","volume":"13","author":"van Der Lee","year":"2008","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.neuropharm.2026.110967_bib94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-9256-1-9","article-title":"The amygdala between sensation and affect: a role in pain","volume":"1","author":"Veinante","year":"2013","journal-title":"J Mol Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110967_bib95","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1046\/j.1471-4159.1999.0731212.x","article-title":"In vitro autoradiographic visualization of guanosine-5'-O-(3-[35S]thio)triphosphate binding stimulated by sphingosine 1-phosphate and lysophosphatidic acid","volume":"73","author":"Waeber","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110967_bib96","article-title":"Multimodal mapping of cell types and projections in the central nucleus of the amygdala","volume":"12","author":"Wang","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.110967_bib97","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.celrep.2019.09.011","article-title":"Dual and opposing functions of the central amygdala in the modulation of pain","volume":"29","author":"Wilson","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.110967_bib98","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/1087057113488629","article-title":"Predictability of peripheral lymphocyte reduction of novel S1P1 agonists by in vitro GPCR signaling profile","volume":"18","author":"Xu","year":"2013","journal-title":"J. Biomol. Screen"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:06:46Z","timestamp":1778040406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":98,"alternative-id":["S0028390826001401"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110967","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ozanimod and other sphingosine-1-phosphate receptor 1 modulators normalize neuropathic injury-enhanced inhibition of central lateral amygdala neurons expressing corticotropin-releasing hormone","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110967"}}